Tumor-stroma contributes to immunotherapeutic resistance in non-small cell lung cancer via SEMA3C-mediated immunosuppressive tumor microenvironment.

Transl Oncol · 2026 · PMC12857187 · PMID 41558146

Europe PMC DOI

hedged sentence

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

showed a trendP = 0.088so close (0.05 < p ≤ 0.1)

Notably, high TSP scores showed a trend toward enrichment in non-responders (Fisher’s exact test, P = 0.088, Fig. 4 K).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.